Sponsor Pipeline

Renibus Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-14 NCT06092970
An Evaluation of Patient Reported Outcomes and Clinical Outcomes		 critical Trial terminated
2026-08-14 NCT06092970
An Evaluation of Patient Reported Outcomes and Clinical Outcomes		 critical Trial terminated: REN-007 main study failed to meet primary objectives, therefore this extension study was terminated.
2026-08-14 NCT06092970
An Evaluation of Patient Reported Outcomes and Clinical Outcomes		 date change Primary completion moved earlier: 2026-06-30 -> 2026-02-06
2026-08-14 NCT06092970
An Evaluation of Patient Reported Outcomes and Clinical Outcomes		 date change Completion moved earlier: 2026-06-30 -> 2026-02-06
Active Trials by Phase
Phase 3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07355062 A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic… CKD Recruiting
Not specified
NCT07009340 Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass… Post-discharge Outcomes Active, Not Recruiting
Disease Areas
Chronic Kidney Disease (1)
Get alerts when Renibus Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free